Kanna (Sceletium tortuosum) and CBD target anxiety through different neurological pathways, making them suited to different anxiety types and contexts. CBD acts primarily at serotonin 5-HT1A receptors (the same target as buspirone, a prescription anxiolytic) and modulates the endocannabinoid system. A 2019 case series in The Permanente Journal found CBD reduced anxiety in 79% of patients at 25–175mg doses. Kanna's mesembrine alkaloid inhibits serotonin reuptake (similar SSRI mechanism) while nuciferine modulates dopamine, and the PDE4 inhibition from both compounds reduces amygdala threat-response. A 2014 RCT in Neuropsychopharmacology found kanna significantly reduced amygdala response to threatening stimuli. Both work; which is better depends on your specific anxiety type.

CBD vs kanna for generalized anxiety

For ongoing generalized anxiety managed daily: CBD has more accessible evidence at higher doses (50–150mg/day over weeks) and a more extensive safety record in large populations. Kanna has stronger short-term anxiolytic effect at situational doses but slightly less long-term data. If you want consistent daily management without intoxication, CBD is the first-line option due to its broader evidence base and established safety profile.

CBD vs kanna for social anxiety

Kanna has a meaningful edge for social anxiety specifically. The 2014 RCT directly measured amygdala response to social threat stimuli — the neural mechanism of social anxiety — and found kanna reduced it significantly. CBD's evidence for social anxiety comes from a 2011 study (simulated public speaking) showing anxiety reduction, but the amygdala-targeted mechanism of kanna makes it more directly relevant to the brain circuit driving social anxiety. For pre-event social anxiety dosing, kanna's faster-acting, more social-specific effect profile makes it the better choice.

Can you combine kanna and CBD?

Yes — kanna and CBD target complementary pathways. CBD's 5-HT1A activity and endocannabinoid modulation doesn't interfere with kanna's serotonin reuptake inhibition at standard doses. Many users report combining 25–50mg CBD with a standard kanna dose for general daytime anxiety management. Do not combine kanna with SSRIs, SNRIs, or MAOIs regardless of CBD status — the serotonergic interaction is the primary safety concern with kanna. Find both kanna and CBD at Elevated Haze.